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Dear Editor, 
Tuberculosis (TB) still becomes a high burden 
for Indonesia, which is not only because of the 
TB itself (Al Asyary, 2017; A. Asyary, 
Purwantyastuti, & Junadi, 2017), but also its 
resistant to several first-line TB drug variance, 
namely multidrug resistant tuberculosis (MDR-
TB). I read previous publication on 
determinant of successful MDR-TB treatment 
at Palu, Sulawesi Tengah Province, Indonesia 
(Napirah, Wandira, & Aulia, 2017). Napirah, 
et al. presented a cross sectional study in 
tertiary healthcare facility, which revealed that 
there were significant relationships between 
knowledge, regularity of treatment, drug 
control, drug side effects, quality of health 
staffs and the success of multidrug resistant 
tuberculosis program (Napirah et al., 2017).  
 
I appreciate that these findings are the 
meaningful results, particularly to mitigate and 
controlled MDR-TB prevalence in under-
resourced TB control setting in Indonesia. 
However, I particularly concern about the 
confounding and bias effects  by its analytical 
approaches which was using bivariate analysis. 
I wonder how to adjust the effects’ results after 
these variables analyzed using multivariable 
analysis such as simple multiple logistics 
regression (Kleinbaum, Kupper, Nizam, & 
Rosenberg, 2013). Furthermore, this study was 
unable to show the prior TB status of their 
MDR-TB cases whom treated in those 
programs as well as to prevent measurement 
bias, whether it is new case of MDR-TB 
(MDR-TB incidence) or previous cases 
(relapse, default, or failed case). In fact, it is 
estimated that the new MDR-TB cases are 
from the previous cases (Zignol et al., 2006). 
 
The author presents the classification of casual 
TB that possibly develops MDR-TB cases as 
the following (Microbiology Department, 
2010; WHO, 2009): (a) New cases: a patient 
who has not yet treated for TB drug therapy at 
all or had been treated for TB drug therapy for 
less than a month (less than four weeks 
treatment); and (b) Previously treated cases, 
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which comprised of: (1) Relaps: a TB patient 
who currently is diagnosed with smear positive 
of Mycobacterium tuberculosis  sp. (MTB) 
assessments, which had previously completed 
TB treatment before; (2) Default: a patient 
with smear-positive TB, who is interrupting 
TB therapy at least for two months of current 
TB treatment e.g. failed to follow up as the 
main reason; (3) Failure: a patient with smear-
positive TB, who is still experiencing smear 
positive sputum of MTB assessment at least 
for five months of current TB treatment; (4) 
Transfer-in: a TB patient who is being 
transferred from one to another healthcare 
facility. In this case, the patient is usually 
following their TB either for therapy or 
diagnose from limited resourced to tertiary 
health facility, such as health facility with drug 
susceptibility test (DST) for MDR-TB 
diagnosed (Kimerling, Lambregts-Van 
Weezenbeek, & Jaramillo, 2016); and (5) 
Special cases: this case cannot be included in 
all classification, whereas this group is usually 
diagnosed as a chronic case. It consists of prior 
smear-positive TB patients who are confirmed 
as prior same outcome (smear positive TB) 
after current TB re-treatment. 
 
It can be shown that the prior TB status is an 
important milestone that leads to the adjustable 
outcome of MDR-TB associations. It is 
therefore essential to affirm the adjusted effect 
of Napiral et al. study’s variables in east 
territory of Indonesia setting with all limited 
resources. 
 
 
 
REFERENCES 
 
Asyary, A. (2017). Childhood tuberculosis: a neglected 
paradigm in developing countries. Public Health 
of Indonesia, 3(1), 7-10.  
Asyary, A., Purwantyastuti, E. T., & Junadi, P. (2017). 
Perceived of healthcare utilization by adult 
pulmonary tuberculosis patients for their children 
in Yogyakarta. Asian Journal of Epidemiology, 
10(2), 72-75.  
Kimerling, M. E., Lambregts-Van Weezenbeek, K., & 
Jaramillo, E. (2016). Programmatic control of 
multidrug-resistant tuberculosis. Tuberc Essent, 
237, 249.  
Kleinbaum, D. G., Kupper, L. L., Nizam, A., & 
Rosenberg, E. S. (2013). Applied regression 
analysis and other multivariable methods: 
Cengage Learning. 
Microbiology Department. (2010). Basic of 
Determination of Tuberculosis Case. Medan: 
Faculty of Medicine, Universitas Sumatera Utara. 
Napirah, M. R., Wandira, B. A., & Aulia, A. (2017). 
FACTORS RELATED TO THE SUCCESS OF 
THE TREATMENT PROGRAM OF 
MULTIDRUG-RESISTANT TUBERCULOSIS 
IN POLYCLINIC OF MDR-TB OF THE 
GENERAL HOSPITAL OF UNDATA PALU, 
INDONESIA. Public Health of Indonesia, 3(4), 
162-166.  
WHO. (2009). Guidelines for surveillance of drug 
resistance in tuberculosis: World Health, 
Organization. 
Zignol, M., Hosseini, M. S., Wright, A., Weezenbeek, C. 
L. v., Nunn, P., Watt, C. J., . . . Dye, C. (2006). 
Global incidence of multidrug-resistant 
tuberculosis. The Journal of infectious diseases, 
194(4), 479-485. 
 
Cite this article as: Al Asyary. (2018). 
Response: Factors Related to the Success of the 
Treatment Program of Multidrug-Resistant 
Tuberculosis in Polyclinic of MDR-TB of the 
General Hospital of Undata Palu, Indonesia.  
Public Health of Indonesia, 4(1):xxx 
 
161 
